The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

被引：324

作者：

Ho, VT ^{[1
]}

Soiffer, RJ ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Dept Adult Oncol, Boston, MA 02115 USA

来源：

BLOOD | 2001年 / 98卷 / 12期

关键词：

D O I：

10.1182/blood.V98.12.3192

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：3192 / 3204

页数：13

共 238 条

[21]

Bensinger WI, 1996, BLOOD, V88, P4132

[22]

BERTHEAS MF, 1991, BLOOD, V78, P3103

[23]

BIERER BE, 1990, TRANSPLANTATION, V49, P1168

[24] Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: A retrospective case-matched study from the European group for blood and marrow transplantation [J].

Bjorkstrand, B ;

Ljungman, P ;

Svensson, H ;

Hermans, J ;

Alegre, A ;

Apperley, J ;

Blade, J ;

Carlson, K ;

Cavo, M ;

Ferrant, A ;

Goldstone, AH ;

deLaurenzi, A ;

Majolino, I ;

Marcus, R ;

Prentice, HG ;

Remes, K ;

Samson, D ;

Sureda, A ;

Verdonck, LF ;

Volin, L ;

Gahrton, G .

BLOOD, 1996, 88 (12) :4711-4718

[25] COBLOCKADE OF THE LFA1-ICAM AND CD28/CTLA4-B7 PATHWAYS IS A HIGHLY EFFECTIVE MEANS OF PREVENTING ACUTE LETHAL GRAFT-VERSUS-HOST DISEASE INDUCED BY FULLY MAJOR HISTOCOMPATIBILITY COMPLEX-DISPARATE DONOR GRAFTS [J].

BLAZAR, BR ;

TAYLOR, PA ;

PANOSKALTSISMORTARI, A ;

GRAY, GS ;

VALLERA, DA .

BLOOD, 1995, 85 (09) :2607-2618

[26]

Blazar BR, 1997, J IMMUNOL, V158, P29

[27]

BLAZAR BR, 1994, BLOOD, V83, P3815

[28]

BORDIGNON C, 1989, BLOOD, V74, P2237

[29]

BOSSERMAN LD, 1989, BONE MARROW TRANSPL, V4, P239

[30]

BOZDECH MJ, 1985, EXP HEMATOL, V13, P1201

← 1 2 3 4 5 6 7 8 9 10 →